| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +6.8% |
| Cost of Revenue | $678.8M | +4.9% |
| Gross Profit | $364.2M | +10.4% |
| R&D Expense | $163.9M | -10.6% |
| SG&A Expense | $235.4M | -1.4% |
| Operating Income | -$155.3M | +28.8% |
| Interest Expense | $27.8M | +191.7% |
| Income Tax | -$530K | -154.1% |
| Net Income | -$164.8M | -26.7% |
| EPS (Basic) | -$1.36 | -17.2% |
| EPS (Diluted) | -$1.36 | -17.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.7M | -16.7% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $48.7M | -5.8% |
| Current Assets | $375.4M | -15.6% |
| Total Assets | $1.01B | -12.2% |
| Current Liabilities | $332.6M | +23.9% |
| Total Liabilities | $1.10B | -1.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.3M | -156.9% |
| Capital Expenditures | $11.2M | -7.0% |
| Investing Cash Flow | $34.4M | -64.7% |
| Financing Cash Flow | -$28.1M | +88.5% |
| Free Cash Flow | -$43.5M | -197.3% |
| Stockholders' Equity |
| -$82.7M |
| -3108.3% |